Authors
Latest:
The Potential Impacts of Targeted Drug Advertising on Social MediaIn part 2 of our video series with drug market experts Luke Turnock, PhD, and Jenny Markell, we explored social media advertisements for prescription drugs and how they may impact patients.
Latest:
The Use of Geographical Information Systems to Improve Vaccine Services, Uptake | NCPDP 2025In her expertise as a leader with the American Pharmacists Association, Brigid Groves, PharmD, MS, provides insights into her work with geographical information systems and maps.
Latest:
Assessing and Treating Opioid Use Disorder in PregnancyOpioid use disorder during pregnancy is stigmatized, but these patients deserve compassionate, nonjudgmental care.
Latest:
8 Secrets That Make Daily Facebook Posts Possible For Any PharmacyNow is the time for independent pharmacies to shine online.
Latest:
Q&A: How ACIP Changes Could Reshape Patient CareKevin W. Cleveland, PharmD, urges evidence-based approaches to immunizations in an era of uncertainty.
Latest:
The Increasingly Relevant Role of PharmacogenomicsPharmacogenomics looks at how genetic influences affect an individual’s response to therapeutic medications.
Latest:
How Technology Can Reduce Pharmacy Staff BurnoutCompanies like ShiftRx are using technology to help solve the staffing shortage crisis in health care.
Latest:
FDA Approves Ceftobiprole Medocaril Sodium for 3 IndicationsThe FDA approved ceftobiprole medocaril sodium for injection (Zevtera) in April 2024.
Latest:
Asembia Does a Great Job Bringing Professionals Together, Experts Say | Asembia 2025The Summit provides a rare opportunity for professionals to dive deep into emerging healthcare technologies and treatment models.
Latest:
Health Care Hiring Trends For 2023 And BeyondHow are hiring trends shaping up for the future of health care?
Latest:
Lecanemab-irmb Approved for Alzheimer DiseaseOn January 6, 2023, the FDA granted lecanemab-irmb (Leqembi) accelerated approval for treating mild cognitive impairment and mild dementia in patients with Alzheimer disease.
Latest:
New Prodrug for ADHD in School-aged ChildrenSer/dex is a dexmethylphenidate-based prodrug for ADHD in patients 6 years and older.
Latest:
Q&A: What AI Is, How It’s Helping Pharmacies with Compliance | NCPDP 2025Stanley V. Campbell, Jr., CEO of EagleForce Associates, Inc., and Yi Deng, PhD, Senior Vice President of Engineering at EagleForce, discuss the basics of AI and how it’s assisting with compliance.
Latest:
Could a Cash-Based System Help Eliminate Health Care Barriers?Disadvantaged groups are feeling the sting of health care costs—so much so that many are foregoing health care because they can’t pay for it.
Latest:
Use This Checklist To Select Your CBD ProductWhat pharmacists need to consider before selling CBD in their stores.
Latest:
OTC Considerations for COVID-19Many individuals have been asking if they can take things at home, such as vitamins and OTC medications, to decrease their risk of contracting the virus or to self-treat themselves
Latest:
Apetamin Gains Popularity on Social Media as Weight Gain DrugApetamin has been promoted worldwide as a weight gain supplement—but what are the dangers of misuse?
Latest:
How to Increase CBD Sales at Your Independent PharmacyTips to help your pharmacy stand out as a knowledgeable CBD retailer.
Latest:
Pharmacists Help Patients Manage Chronic PainChronic pain is associated with a significant financial burden, with an estimated cost placed at $650 billion annually in the US.
Latest:
Opioid Use Disorder Treatment Inconsistent Around United StatesAt the state level, medication treatment rates ranged from 17.7% in Kansas to 82.8% in Maine.
Latest:
Independent Pharmacies Face Mounting Challenges in Modern Health Care Landscape | McKesson ideaShareCrystal Lennartz, president of Health Mart & Health Mart Atlas at McKesson, discusses challenges that independent pharmacies are facing in today's health care landscape.
Latest:
AMD Risk Not Tied to Long-Term Metformin UseThe researchers reported that there was no significant difference in the age-related macular degeneration prevalence among the 3 study groups.
Latest:
New Drug Review: FDA Approves Tryvio for the Treatment of Hypertension in Combination With Other Antihypertensive Drugs to Lower Blood PressureTryvio was given FDA approval on March 19, 2024.
